These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 3010640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Actions of calcium antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro.
    Pernow J, Svenberg T, Lundberg JM.
    Eur J Pharmacol; 1987 Apr 14; 136(2):207-18. PubMed ID: 3595720
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.
    Dahlöf C, Dahlöf P, Tatemoto K, Lundberg JM.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan 14; 328(3):327-30. PubMed ID: 3838576
    [Abstract] [Full Text] [Related]

  • 5. Effects of nifedipine on potassium-induced contraction and noradrenaline release in cerebral and extracranial arteries from rabbit.
    Högestätt ED, Andersson KE, Edvinsson L.
    Acta Physiol Scand; 1982 Feb 14; 114(2):283-96. PubMed ID: 6127868
    [Abstract] [Full Text] [Related]

  • 6. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
    Lundberg JM, Pernow J, Franco-Cereceda A, Rudehill A.
    J Cardiovasc Pharmacol; 1987 Feb 14; 10 Suppl 12():S51-68. PubMed ID: 2455193
    [Abstract] [Full Text] [Related]

  • 7. Modulatory interactions of neuropeptide Y (NPY) on sympathetic neurotransmission.
    Linton-Dahlöf P.
    Acta Physiol Scand Suppl; 1989 Feb 14; 586():1-85. PubMed ID: 2557726
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Co-release and functional interactions of neuropeptide Y and noradrenaline in peripheral sympathetic vascular control.
    Pernow J.
    Acta Physiol Scand Suppl; 1988 Feb 14; 568():1-56. PubMed ID: 3232527
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS, Stjärne P, Anggärd A, Lundberg JM.
    Acta Physiol Scand; 1989 Jan 14; 135(1):17-28. PubMed ID: 2911948
    [Abstract] [Full Text] [Related]

  • 13. BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
    Donoso MV, Steiner M, Huidobro-Toro JP.
    J Pharmacol Exp Ther; 1997 Aug 14; 282(2):691-8. PubMed ID: 9262332
    [Abstract] [Full Text] [Related]

  • 14. Neuropeptide Y and sympathetic vascular control in man.
    Lundberg JM, Torssell L, Sollevi A, Pernow J, Theodorsson Norheim E, Anggård A, Hamberger B.
    Regul Pept; 1985 Dec 14; 13(1):41-52. PubMed ID: 3841402
    [Abstract] [Full Text] [Related]

  • 15. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
    Lundberg JM, Fried G, Pernow J, Theodorsson-Norheim E.
    Acta Physiol Scand; 1986 Feb 14; 126(2):231-8. PubMed ID: 3754683
    [Abstract] [Full Text] [Related]

  • 16. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery.
    Lundberg JM, Pernow J, Tatemoto K, Dahlöf C.
    Acta Physiol Scand; 1985 Apr 14; 123(4):511-3. PubMed ID: 3838851
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of neuropeptide Y-induced augmentation of noradrenaline-induced vasoconstriction by D-myo-inositol 1,2,6-trisphosphate in the rat mesenteric arterial bed.
    Ralevic V, Edvinsson L, Burnstock G.
    Acta Physiol Scand; 1994 Jul 14; 151(3):309-17. PubMed ID: 7976403
    [Abstract] [Full Text] [Related]

  • 18. Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
    Dietrich P, Moleda L, Kees F, Müller M, Straub RH, Hellerbrand C, Wiest R.
    J Hepatol; 2013 Feb 14; 58(2):254-61. PubMed ID: 23041305
    [Abstract] [Full Text] [Related]

  • 19. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R, Jurzik L, Moleda L, Froh M, Schnabl B, von Hörsten S, Schölmerich J, Straub RH.
    J Hepatol; 2006 Mar 14; 44(3):512-9. PubMed ID: 16324766
    [Abstract] [Full Text] [Related]

  • 20. Neuropeptide Y preferentially potentiates responses to adrenergic nerve stimulation by increasing rate of contraction.
    Vu HQ, Budai D, Duckles SP.
    J Pharmacol Exp Ther; 1989 Dec 14; 251(3):852-7. PubMed ID: 2600818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.